Doerfler Douglas

Doerfler Douglas serves as the President and CEO of MaxCyte, Inc., a company specializing in cell-based therapies and drug discovery solutions. Under his leadership, MaxCyte has focused on innovative approaches within the healthcare sector, particularly in the development of its proprietary technology platform. Recent insider trading activity from December 1 to December 6, 2023, reveals a total of three sales, with the largest transaction amounting to $514.1K on December 6, indicating a concentrated pattern of selling activity during this brief period.